US FDA Drug Center ‘Snapshots’ Show Progress, But Are They Measuring The Right Thing?
US FDA trial enrollment data show improving enrollment across broad demographic definitions, but stakeholders agree more attention is needed for complex subgroups. Could larger trials be part of the answer?
